TITLE

Pegloticase Injection (KrystexxaTM)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
October 2010
SOURCE
Internal Medicine Alert;10/29/2010, Vol. 32 Issue 20, p158
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the Krystexxaâ„¢ pegloticase injection from Savient Pharmaceuticals Inc. which is intended for hyperuricemia treatment. It mentions the potential side effects of the injection such as anaphylaxis and infusion reactions. It explores the two randomized, placebo-controlled trials which revealed the injection's effectiveness. It adds that pegloticase serves as an alternative treatment for the hyperuricemia patients who did not respond to standard therapy.
ACCESSION #
56440536

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics